<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1375</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2023-22-1-68-75</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Nanoprobes based on fluorescent semiconductor nanocrystals and single-domain antibodies for highly sensitive detection of epidermal growth factor receptor in tumor cells</article-title><trans-title-group xml:lang="ru"><trans-title>Нанозонды на основе флуоресцентных полупроводниковых нанокристаллов и однодоменных антител для высокочувствительной детекции рецептора эпидермального фактора роста в опухолевых клетках</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6956-5654</contrib-id><name-alternatives><name xml:lang="en"><surname>Nifontova</surname><given-names>G. O.</given-names></name><name xml:lang="ru"><surname>Нифонтова</surname><given-names>Г. О.</given-names></name></name-alternatives><address><country country="FR">France</country></address><bio xml:lang="en"><p>51 Cognacq Jay, 51100 Reims, France</p></bio><bio xml:lang="ru"><p>Франция, 51100 Реймс, ул. Когнак Жэ, 51</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1394-7768</contrib-id><name-alternatives><name xml:lang="en"><surname>Kalenichenko</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Калениченко</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="FR">France</country></address><bio xml:lang="en"><p>51 Cognacq Jay, 51100 Reims, France</p></bio><bio xml:lang="ru"><p>Франция, 51100 Реймс, ул. Когнак Жэ, 51</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6688-8423</contrib-id><name-alternatives><name xml:lang="en"><surname>Baryshnikova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Барышникова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, 115522 Moscow, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4755-5313</contrib-id><name-alternatives><name xml:lang="en"><surname>Sokolova</surname><given-names>Z. A.</given-names></name><name xml:lang="ru"><surname>Соколова</surname><given-names>З. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, 115522 Moscow, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff8"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2878-8376</contrib-id><name-alternatives><name xml:lang="en"><surname>Samokhvalov</surname><given-names>P. S.</given-names></name><name xml:lang="ru"><surname>Самохвалов</surname><given-names>П. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 31 Kashirskoe Shosse, 115409 Moscow, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115409 Москва, Каширское шоссе, 31</p></bio></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1930-5424</contrib-id><name-alternatives><name xml:lang="en"><surname>Karaulov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Караулов</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Bld. 2, 8 Trubetskaya, 119992 Moscow, Russia</p></bio><bio xml:lang="ru"><p>Россия, 119992 Москва, ул. Трубецкая, 8, стр. 2</p></bio><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2796-7898</contrib-id><name-alternatives><name xml:lang="en"><surname>Sukhanova</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Суханова</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="FR">France</country></address><bio xml:lang="en"><p>51 Cognacq Jay, 51100 Reims, France</p></bio><bio xml:lang="ru"><p>Франция, 51100 Реймс, ул. Когнак Жэ, 51</p></bio></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8391-040X</contrib-id><name-alternatives><name xml:lang="en"><surname>Nabiev</surname><given-names>I. R.</given-names></name><name xml:lang="ru"><surname>Набиев</surname><given-names>И. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Igor Rufailovich Nabiev </p><p>51 Cognacq Jay, 51100 Reims, France</p><p>Bld. 2, 8 Trubetskaya, 119992 Moscow, Russia</p></bio><bio xml:lang="ru"><p>Игорь Руфаилович Набиев</p><p>Франция, 51100 Реймс, ул. Когнак Жэ, 51</p><p>Россия, 119992 Москва, ул. Трубецкая, 8, стр. 2</p></bio><email>igor.nabiev@gmail.com</email><xref ref-type="aff" rid="aff6"/><xref ref-type="aff" rid="aff7"/><xref ref-type="aff" rid="aff8"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">University of Reims Champagne-Ardenne</institution></aff><aff><institution xml:lang="ru">Университет Реймса Шампань-Арденн</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="ru"></institution></aff><aff><institution xml:lang="en">National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="ru">ФГАОУ ВО «Национальный исследовательский ядерный университет «МИФИ»</institution></aff><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="ru">ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution></aff><aff><institution xml:lang="en">University of Reims Champagne-Ardenne</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Университет Реймса Шампань-Арденн</institution></aff></aff-alternatives><aff id="aff7"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution></aff><aff id="aff8"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2023-04-18" publication-format="electronic"><day>18</day><month>04</month><year>2023</year></pub-date><volume>22</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>68</fpage><lpage>75</lpage><history><date date-type="received" iso-8601-date="2022-10-24"><day>24</day><month>10</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-04-17"><day>17</day><month>04</month><year>2023</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/1375">https://bioterapevt.abvpress.ru/jour/article/view/1375</self-uri><abstract xml:lang="en"><p><bold>Background</bold>. The development of highly oriented conjugates of quantum dots (QDs) and single-domain antibodies (sdAbs) as innovative fluorescence imaging nanoprobes that specifically recognize tumor biomarkers, in particular, epidermal growth factor receptor (EGFR), is a promising approach to improving immunohistochemical tumor typing.</p><p><bold>Aim.</bold> The study was aimed at developing fluorescent nanoprobes based on QDs and sdAbs that specifically recognize EGFR, as well as evaluating their functional characteristics (size and optical properties) and functional activity.</p><p><bold>Materials and methods</bold>. QDs were obtained using high-temperature organometallic synthesis and transferred into the aqueous phase by means of stepwise replacement of ligands on the QD surface. The QDs and sdAbs were conjugated in an oriented manner using a bifunctional cross-linking agent. Detailed characteristics of the resulting conjugates were analyzed by the dynamic light scattering and immunoassay methods. Functional activity was assessed on the model human epidermoid carcinoma cells line A431.</p><p><bold>Results</bold>. The QD–sdAb conjugates have been standardized in terms of control parameters determining their functional activity, in particular, hydrodynamic diameter and efficiency of binding with target tumor cells. They are characterized by high dispersity, homogeneity, and specific functional activity towards their molecular target.</p><p><bold>Conclusion</bold>. The results demonstrate the potential use of the designed QD–sdAb conjugates for EGRF detection in immunohistochemical typing of tumor.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Разработка инновационных средств флуоресцентной визуализации, представляющих собой нанозонды – конъюгаты квантовых точек (КТ) и однодоменных антител (одАТ), специфически распознающих биомаркеры опухолей, в частности рецептор эпидермального фактора роста (EGFR), является актуальным направлением усовершенствования подходов к иммуногистохимическому типированию опухолей.</p><p><bold>Цель исследования</bold> – разработка флуоресцентных нанозондов на основе КТ и одАТ, специфически распознающих EGFR, а также оценка их функциональных характеристик (размера и оптических свойств) и функциональной активности.</p><p><bold>Материалы и методы</bold>. КТ получены методом металлоорганического высокотемпературного синтеза и переведены в водную фазу посредством поэтапной замены лигандов на поверхности КТ. Ориентированную конъюгацию КТ и одАТ осуществляли с использованием бифункционального агента для кросс-сшивки. Полученные конъюгаты комплексно охарактеризованы методами динамического светорассеяния и иммуноанализа. Функциональную активность оценивали на модельной линии опухолевых клеток эпидермоидной карциномы А431.</p><p><bold>Результаты</bold>. Разработанные конъюгаты стандартизованы по контрольным параметрам, обусловливающим их функциональную активность, в частности по гидродинамическому диаметру и эффективности связывания с опухолевыми клетками-мишенями, и характеризуются высокой дисперсностью, гомогенностью, специфической функциональной активностью по отношению к исследованной молекулярной мишени.</p><p><bold>Заключение</bold>. Полученные результаты демонстрируют потенциальную возможность использования разработанных конъюгатов КТ и одАТ для детекции EGRF при иммуногистохимическом типировании опухолей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>quantum dots</kwd><kwd>single-domain antibodies</kwd><kwd>conjugation</kwd><kwd>nanoprobes for fluorescent detection</kwd><kwd>epidermal growth factor receptor</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>квантовые точки</kwd><kwd>однодоменные антитела</kwd><kwd>конъюгация</kwd><kwd>нанозонды для флуоресцентной детекции</kwd><kwd>рецептор эпидермального фактора роста</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This work was supported by the Ministry of Science and Higher Education of the Russian Federation through the grant No 075-15-2021- 937 (NanoToBio project).</funding-statement><funding-statement xml:lang="ru">Данная работа была поддержана грантом № 075-15-2021-937 (проект NanoToBio) Министерства науки и высшего образования Российской Федерации.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dagogo-Jack I., Shaw A. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 2018;15(2):81–94. DOI: 10.1038/nrclinonc.2017.166</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Gupta G.K., Collier A.L., Lee D. et al. Perspectives on triplenegative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies. Cancers 2020;12(9):2392. DOI: 10.3390/cancers12092392</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sheikine Y., Rangachari D., McDonald D.C. et al. EGFR testing in advanced non-small-cell lung cancer, a mini-review. Clin Lung Cancer 2016;17(6):483–92. DOI: 10.1016/j.cllc.2016.05.016</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Inamura K. Update on immunohistochemistry for the diagnosis of lung cancer. Cancers 2018;10(3):72. DOI: 10.3390/cancers10030072</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Mehner C., Oberg A.L., Goergen K.M. et al. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review. Genes Cancer 2017;8(5–6):589–99. DOI: 10.18632/genesandcancer.142</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Fenizia F., De Luca A., Pasquale R. et al. EGFR mutations in lung cancer: from tissue testing to liquid biopsy. Future Oncol 2015;11(11):1611–23. DOI: 10.2217/fon.15.23</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zhang W., Hubbard A., Jones T. et al. Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies. Lab Invest 2017;97(7):873–85. DOI: 10.1038/labinvest.2017.37</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wan H., Yue J., Zhu S. et al. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues. Nat Commun 2018;9(1):1171. DOI: 10.1038/s41467-018-03505-4</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Montecinos-Franjola F., Lin J.Y., Rodriguez E.A. Fluorescent proteins for in vivo imaging, where’s the biliverdin? Biochem Soc Trans 2020;48(6):2657–67. DOI: 10.1042/BST20200444</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Deshayes S., Divita G. Fluorescence technologies for monitoring interactions between biological molecules in vitro. Prog Mol Biol Transl Sci 2013;113:109–43. DOI: 10.1016/B978-0-12-386932-6.00004-1</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bilan R., Nabiev I., Sukhanova A. Quantum dot-based nanotools for bioimaging, diagnostics, and drug delivery. Chembiochem 2016;17(22):2103–114. DOI: 10.1002/cbic.201600357</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Nifontova G., Krivenkov V., Zvaigzne M. et al. Controlling charge transfer from quantum dots to polyelectrolyte layers extends prospective applications of magneto-optical microcapsules. ACS Appl Mater Interfaces 2020;12(32):35882–94. DOI: 10.1021/acsami.0c08715</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Dumoulin M., Conrath K., Van Meirhaeghe A. et al. Singledomain antibody fragments with high conformational stability. Protein Sci 2002;11(3):500–15. DOI: 10.1110/ps.34602</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Staus D.P., Wingler L.M., Strachan R.T. et al. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies. Mol Pharmacol 2014;85(3):472–81. DOI: 10.1124/mol.113.089516</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Liu J.L., Goldman E.R., Zabetakis D. et al. Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bond. Microbial Cell Factories 2015;14(1):158. DOI: 10.1186/s12934-015-0340-3</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ramos-Gomes F., Bode J., Sukhanova A. et al. Single- and twophoton imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots. Sci Rep 2018;8(1):4595. DOI: 10.1038/s41598-018-22973-8</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Brazhnik K., Nabiev I., Sukhanova A. Oriented conjugation of single-domain antibodies and quantum dots. In: Quantum Dots: Applications in Biology. Methods in Molecular Biology. N.-Y.: 2014. P. 129–140.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Sukhanova A., Ramos-Gomes F., Chames P. et al. Multiphoton deep-tissue imaging of micrometastases and disseminated cancer cells using conjugates of quantum dots and single-domain antibodies. In: Multiplexed Imaging. Methods in Molecular Biology. N.-Y.: 2021. P. 105–123.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Dang X., Bardhan N.M., Qi J. et al. Deep-tissue optical imaging of near cellular-sized features. SciRep 2019;9(1):3873. DOI: 10.1038/s41598-019-39502-w</mixed-citation></ref></ref-list></back></article>
